by | Jun 1, 2026 | DiPersio, John, Rettig, Michael, Ruminski, Peter
— Published date: 6/2/2026
Value Proposition: VLA4 inhibitors that significantly mobilize hematopoietic stem cells from bone marrow.
Technology Description
Researchers at Washington University in St. Louis have developed novel VLA4 inhibitors for mobilizing hematopoietic stem cells in peripheral …
by | Dec 8, 2020 | Christopher, Matthew, DiPersio, John, Ley, Timothy, Petti, Allegra, Rettig, Michael
— Technology Description
Researchers at Washington University in St. Louis have discovered that interferon-gamma treatment could potentially prevent relapse after hematopoietic stem cell transplantation (HCT) treatment by making the cancer cells more visible to the donor immune cells. This technolog…
